CORCEPT THERAPEUTICS INCORPORATED - COMMON STOCK
24.52
03-May-24 15:59:59
15 minutes delayed
Stocks
-0.54
-2.15%
Today's range
23.11 - 25.22
ISIN
N/A
Source
NASDAQ
-
14 Feb 2023 16:05:00 By Nasdaq GlobeNewswire
-
13 Feb 2023 08:00:00 By Nasdaq GlobeNewswire
-
Corcept Therapeutics Provides Miricorilant Clinical Development Update
08 Dec 2022 08:00:02 By Nasdaq GlobeNewswire
-
Corcept Therapeutics Settles Patent Litigation with Hikma Pharmaceuticals
08 Dec 2022 08:00:01 By Nasdaq GlobeNewswire
-
Corcept Therapeutics Announces Third Quarter Financial Results and Provides Corporate Update
03 Nov 2022 16:05:02 By Nasdaq GlobeNewswire
-
27 Oct 2022 16:05:01 By Nasdaq GlobeNewswire
-
Corcept Therapeutics Initiates DAZALS – A Phase 2 Trial in Amyotrophic Lateral Sclerosis (ALS)
11 Oct 2022 16:05:00 By Nasdaq GlobeNewswire
-
Corcept Therapeutics Announces Second Quarter Financial Results and Provides Corporate Update
03 Aug 2022 16:05:00 By Nasdaq GlobeNewswire
-
29 Jun 2022 16:05:00 By Nasdaq GlobeNewswire
-
06 Jun 2022 08:00:02 By Nasdaq GlobeNewswire
-
Corcept Therapeutics Announces First Quarter Financial Results And Provides Corporate Update
05 May 2022 16:05:01 By Nasdaq GlobeNewswire
-
28 Apr 2022 16:05:00 By Nasdaq GlobeNewswire
-
Corcept Therapeutics Announces Appointment of Three Senior Leaders
07 Apr 2022 16:05:00 By Nasdaq GlobeNewswire
-
04 Apr 2022 16:05:00 By Nasdaq GlobeNewswire
-
30 Mar 2022 16:05:00 By Nasdaq GlobeNewswire
-
Corcept Therapeutics to Host Ovarian Cancer Program Update on Thursday, March 31, 2022
01 Mar 2022 16:05:01 By Nasdaq GlobeNewswire
-
15 Feb 2022 16:05:00 By Nasdaq GlobeNewswire
-
08 Feb 2022 16:05:00 By Nasdaq GlobeNewswire
-
Corcept Therapeutics Announces Final Results of Previously Announced Tender Offer
20 Dec 2021 16:05:00 By Nasdaq GlobeNewswire
-
Corcept Therapeutics Announces Preliminary Results of Previously Announced Tender Offer
16 Dec 2021 08:00:02 By Nasdaq GlobeNewswire